Division of Transfusion Medicine


Clinical Services

The Division of Transfusion Medicine supports one of the largest transfusion services in the country transfusing more than 75,000 units of red cells and 70,000 units of platelets annually. The service covers 10 UPMC hospitals, providing a broad experience in both adult and pediatric transfusion medicine. Large trauma, organ transplant and cancer programs pose the greatest demands on the transfusion service and provide a rich source of patients and clinical material for academic and research pursuits.

Research Activities

  • Epidemiology of transfusion - the division participates in the NHLBI Recipient Epidemiology and Transfusion Study (REDSIII) which performs epidemiologic studies of patient transfusion outcomes and donor safety with an emphasis on iron deficiency.

  • NIH-funded randomized trial of tranexamic acid in hematology-oncology patients.
  • Other areas of interest include red cell storage in-vitro abnormalities and adverse effects of transfusion including transfusion related acute lung injury (TRALI), and transfusion associated circulatory overload (TACO).


The Division of Transfusion Medicine is responsible for all pathology resident teaching including apheresis and coagulation. Hematology/oncology fellows in both the adult and pediatric programs and medical students also participate in the rotation. Division faculty also perform numerous teaching activities for medical and surgical housestaff and nurses.


The division sponsors a joint one year ACGME accredited fellowship with the Institute for Transfusion Medicine. The fellowship covers all aspects of transfusion medicine including therapeutic apheresis, stem cell collection and processing and blood center activities. A new one year fellowship program in coagulation was recently launched providing both clinical and laboratory training in hemostasis and thrombosis.